Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Breast (Edinburgh, Scotland)|June 3, 2026
Real-world use of neratinib as extended adjuvant therapy in HER2-positive early-stage breast cancer: a multicentre study in mainland China and Hong KongNilupai Abudureheiyimu, Yueran Jia, Zexi Peng, et al.
BMJ Public Health|May 20, 2026
Real-world evidence of mammography screening from the Hong Kong Breast Cancer Registry: a cost minimisation analysis of 15 144 patients with breast cancerZiyu Hao, Amy Lam, Yaxin Hu, et al.
Cancer Research and Treatment|June 6, 2019
BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 TherapySung-Bae Kim, In-Gu Do, Janice Tsang, et al.
Scientific Reports|June 14, 2023
Knowledge, attitudes and intention on fertility preservation among breast cancer patientsJennifer K Y Ko, Charleen S Y Cheung, Heidi H Y Cheng, et al.
Clinical Medicine Insights. Oncology|January 27, 2025
Modifiable Risk Factors Including Self-Perceived Stress for Breast Cancer in Hong Kong: A Case-Control Study of 10 757 SubjectWinnie Yeo, Lok-Wa Yuen, Kelvin Kam-Fai Tsoi, et al.
Breast Cancer Research and Treatment|September 23, 2021
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimensMing Shen Dai, Yin Hsun Feng, Shang Wen Chen, et al.
Pageof 2